Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Idaba urges Benefitfocus to form board to conduct review of alternatives » 09:18
02/11/21
02/11
09:18
02/11/21
09:18
BNFT

Benefitfocus

$15.71 /

+0.97 (+6.58%)

ndaba Capital Management,…

ndaba Capital Management, L.P., a significant shareholder of Benefitfocus, issued a letter to the company's Board of Directors. In addition, Indaba filed a Schedule 13D Amendment with the U.S. SEC and disclosed its recent communications with the Company. The letter says in part: "In addition to owning approximately 9.6% of the Company's outstanding common shares, we hold approximately 22.9% of the outstanding issue of the 1.25% convertible senior notes. We are writing to you today to convey three primary points: We are extremely disappointed with the Board of Directors' decision to undermine our private discussions by unilaterally announcing incremental governance changes that should represent the start - not the conclusion - of boardroom improvements. The Company's long-term underperformance and years of negative returns stem from an array of governance, operational and strategic failures that the Board still seems reluctant to substantively address. The Company should adopt our logical suggestions, that include refreshing the Board with additional, diverse, independent directors and forming a special committee to conduct a credible review of strategic alternatives, including a sale of Benefitfocus."

ShowHide Related Items >><<
BNFT Benefitfocus
$15.71 /

+0.97 (+6.58%)

BNFT Benefitfocus
$15.71 /

+0.97 (+6.58%)

01/27/21 Piper Sandler
Benefitfocus price target lowered to $20 from $29 at Piper Sandler
01/25/21 Raymond James
Benefitfocus did not bid on South Carolina contract, says Raymond James
01/25/21 Raymond James
South Carolina award 'a lost opportunity' for Benefitfocus, says Raymond James
01/21/21 Raymond James
Benefitfocus downgraded at Raymond James on 'aggressive' consensus estimates
BNFT Benefitfocus
$15.71 /

+0.97 (+6.58%)

Over a month ago
Recommendations
Benefitfocus price target lowered to $20 from $29 at Piper Sandler » 04:57
01/27/21
01/27
04:57
01/27/21
04:57
BNFT

Benefitfocus

$13.49 /

-0.41 (-2.95%)

Piper Sandler analyst…

Piper Sandler analyst Sean Wieland lowered the firm's price target on Benefitfocus to $20 from $29 and keeps an Overweight rating on the shares. The analyst revised his model to more closely align with recent company commentary regarding the "suppressive impact" of COVID-19 on the fiscal 2020 benefits selling season. He's "encouraged" by Benefitfocus' renewed focus on software-as-a-service based, recurring revenue, but sees a lack visibility and recognizes the "execution risk inherent to this, and every, potential recovery."

ShowHide Related Items >><<
BNFT Benefitfocus
$13.49 /

-0.41 (-2.95%)

BNFT Benefitfocus
$13.49 /

-0.41 (-2.95%)

01/25/21 Raymond James
Benefitfocus did not bid on South Carolina contract, says Raymond James
01/25/21 Raymond James
South Carolina award 'a lost opportunity' for Benefitfocus, says Raymond James
01/21/21 Raymond James
Benefitfocus downgraded at Raymond James on 'aggressive' consensus estimates
01/21/21 Raymond James
Benefitfocus downgraded to Market Perform from Outperform at Raymond James
BNFT Benefitfocus
$13.49 /

-0.41 (-2.95%)

Recommendations
Benefitfocus did not bid on South Carolina contract, says Raymond James » 22:21
01/25/21
01/25
22:21
01/25/21
22:21
BNFT

Benefitfocus

$13.90 /

-0.13 (-0.93%)

Raymond James analyst…

Raymond James analyst Brian Peterson corrects his prior research note earlier today that called South Carolina's award for statewide benefits administration system contract to Morneau Shepell a "missed opportunity" for Benefitfocus. The analyst states that after speaking with the company, he learned that Benefitfocus did not bid on the opportunity as the RFP called for a perpetual software license - a model which the company does not offer. Peterson still keeps his Market Perform on Benefitfocus shares.

ShowHide Related Items >><<
BNFT Benefitfocus
$13.90 /

-0.13 (-0.93%)

BNFT Benefitfocus
$13.90 /

-0.13 (-0.93%)

01/25/21 Raymond James
South Carolina award 'a lost opportunity' for Benefitfocus, says Raymond James
01/21/21 Raymond James
Benefitfocus downgraded at Raymond James on 'aggressive' consensus estimates
01/21/21 Raymond James
Benefitfocus downgraded to Market Perform from Outperform at Raymond James
11/06/20 Cantor Fitzgerald
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald
BNFT Benefitfocus
$13.90 /

-0.13 (-0.93%)

Recommendations
South Carolina award 'a lost opportunity' for Benefitfocus, says Raymond James » 16:02
01/25/21
01/25
16:02
01/25/21
16:02
BNFT

Benefitfocus

$13.84 /

-0.19 (-1.35%)

Raymond James analyst…

Raymond James analyst Brian Peterson notes that the state of South Carolina announced that it would award its statewide benefits administration system contract to Morneau Shepell. The news is relevant for Benefitfocus as this represent one of the larger contract opportunities that the analyst was tracking for the company, with the contract amounting to about $41M over 7 years. While Peterson doesn't yet have details on how much functionality versus price played a role in the state's decision, he was optimistic that Benefitfocus' home court advantage would have given them an advantage in securing the business. This takes a potential opportunity off the board, the analyst adds. He has a Market Perform on the shares.

ShowHide Related Items >><<
BNFT Benefitfocus
$13.84 /

-0.19 (-1.35%)

BNFT Benefitfocus
$13.84 /

-0.19 (-1.35%)

01/21/21 Raymond James
Benefitfocus downgraded at Raymond James on 'aggressive' consensus estimates
01/21/21 Raymond James
Benefitfocus downgraded to Market Perform from Outperform at Raymond James
11/06/20 Cantor Fitzgerald
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald
11/06/20 Cantor Fitzgerald
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald
BNFT Benefitfocus
$13.84 /

-0.19 (-1.35%)

Downgrade
Benefitfocus downgraded at Raymond James on 'aggressive' consensus estimates » 07:22
01/21/21
01/21
07:22
01/21/21
07:22
BNFT

Benefitfocus

$14.43 /

-0.19 (-1.30%)

Raymond James analyst…

Raymond James analyst Brian Peterson downgraded Benefitfocus to Market Perform from Outperform without a price target. Peterson expects the initial 2021 revenue outlook to fall short of consensus projections and doesn't believe the consensus properly reflects incremental growth drivers for 2021. The analyst notes that the downgrade is in no way reflective on recently appointed CEO Steve Swad, who Peterson expects to drive improved margin and cash flow levels over the next several years.

ShowHide Related Items >><<
BNFT Benefitfocus
$14.43 /

-0.19 (-1.30%)

BNFT Benefitfocus
$14.43 /

-0.19 (-1.30%)

01/21/21 Raymond James
Benefitfocus downgraded to Market Perform from Outperform at Raymond James
11/06/20 Cantor Fitzgerald
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald
11/06/20 Cantor Fitzgerald
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald
08/06/20 Piper Sandler
Benefitfocus price target raised to $30 from $26 at Piper Sandler
BNFT Benefitfocus
$14.43 /

-0.19 (-1.30%)

Downgrade
Benefitfocus downgraded to Market Perform from Outperform at Raymond James » 04:48
01/21/21
01/21
04:48
01/21/21
04:48
BNFT

Benefitfocus

$14.43 /

-0.19 (-1.30%)

Raymond James analyst…

Raymond James analyst Brian Peterson downgraded Benefitfocus to Market Perform from Outperform without a price target. The analyst views 2021 consensus estimates as "aggressive."

ShowHide Related Items >><<
BNFT Benefitfocus
$14.43 /

-0.19 (-1.30%)

BNFT Benefitfocus
$14.43 /

-0.19 (-1.30%)

11/06/20 Cantor Fitzgerald
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald
11/06/20 Cantor Fitzgerald
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald
08/06/20 Piper Sandler
Benefitfocus price target raised to $30 from $26 at Piper Sandler
06/29/20 Goldman Sachs
Benefitfocus price target raised to $12 from $11 at Goldman Sachs
BNFT Benefitfocus
$14.43 /

-0.19 (-1.30%)

Over a quarter ago
Downgrade
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald » 07:16
11/06/20
11/06
07:16
11/06/20
07:16
BNFT

Benefitfocus

$10.86 /

+0.44 (+4.22%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Steven Halper downgraded Benefitfocus to Neutral from Overweight with a price target of $12, down from $20, following the company's Q3 results. The analyst does not expect many positive catalysts for the next 2-3 quarters, and COVID continues to create a challenging near-term headwind. With limited upside potential, Halper says the risk/reward tradeoff is no longer compelling, and needs to see a return to more consistent, solid growth before becoming more constructive on the shares.

ShowHide Related Items >><<
BNFT Benefitfocus
$10.86 /

+0.44 (+4.22%)

BNFT Benefitfocus
$10.86 /

+0.44 (+4.22%)

11/06/20 Cantor Fitzgerald
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald
08/06/20 Piper Sandler
Benefitfocus price target raised to $30 from $26 at Piper Sandler
06/29/20 Goldman Sachs
Benefitfocus price target raised to $12 from $11 at Goldman Sachs
05/07/20 Piper Sandler
Benefitfocus price target lowered to $26 from $35 at Piper Sandler
BNFT Benefitfocus
$10.86 /

+0.44 (+4.22%)

Downgrade
Benefitfocus downgraded to Neutral from Overweight at Cantor Fitzgerald » 06:17
11/06/20
11/06
06:17
11/06/20
06:17
BNFT

Benefitfocus

$10.86 /

+0.44 (+4.22%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Steven Halper downgraded Benefitfocus to Neutral from Overweight with a $12 price target.

ShowHide Related Items >><<
BNFT Benefitfocus
$10.86 /

+0.44 (+4.22%)

BNFT Benefitfocus
$10.86 /

+0.44 (+4.22%)

08/06/20 Piper Sandler
Benefitfocus price target raised to $30 from $26 at Piper Sandler
06/29/20 Goldman Sachs
Benefitfocus price target raised to $12 from $11 at Goldman Sachs
05/07/20 Piper Sandler
Benefitfocus price target lowered to $26 from $35 at Piper Sandler
04/02/20 Cantor Fitzgerald
Benefitfocus shares attractive at current levels, says Cantor Fitzgerald
BNFT Benefitfocus
$10.86 /

+0.44 (+4.22%)

Hot Stocks
Benefitfocus appoints John Thomas as Chief Data Officer » 08:31
11/02/20
11/02
08:31
11/02/20
08:31
BNFT

Benefitfocus

$10.31 /

-0.3 (-2.83%)

Benefitfocus announces…

Benefitfocus announces the appointment of John Thomas to the newly created role of Chief Data Officer. Thomas will lead the company's data strategy and work with its technology organization to define and deliver new data-driven applications that delight Benefitfocus' customers and strengthen its market-leading benefits technology platform. Thomas has more than a decade of data experience in mobile analytics, customer journey optimization, social media and online advertising. He formerly served as executive vice president of data science at Red Ventures, is the current president of the Analytics & Big Data Society, and is an advisory board member for Wake Forest University's Masters of Business Analytics program. Thomas holds a master's degree and a Ph.D. in computer science from Dartmouth College and a bachelor's degree in mathematics and computer science from Gettysburg College.

ShowHide Related Items >><<
BNFT Benefitfocus
$10.31 /

-0.3 (-2.83%)

BNFT Benefitfocus
$10.31 /

-0.3 (-2.83%)

08/06/20 Piper Sandler
Benefitfocus price target raised to $30 from $26 at Piper Sandler
06/29/20 Goldman Sachs
Benefitfocus price target raised to $12 from $11 at Goldman Sachs
05/07/20 Piper Sandler
Benefitfocus price target lowered to $26 from $35 at Piper Sandler
04/02/20 Cantor Fitzgerald
Benefitfocus shares attractive at current levels, says Cantor Fitzgerald
BNFT Benefitfocus
$10.31 /

-0.3 (-2.83%)

Hot Stocks
Benefitfocus appoints Robin Kirby as Chief Human Resources Officer » 08:57
09/08/20
09/08
08:57
09/08/20
08:57
BNFT

Benefitfocus

$10.11 /

+0.17 (+1.71%)

Benefitfocus announced…

Benefitfocus announced Robin Kirby joined the company as its Chief Human Resources Officer. Kirby formerly served as Senior Vice President of HR for USAA and is a current member of the Forbes HR Council. Kirby will be responsible for Benefitfocus' future-of-work strategies and expanding its talent acquisition and development capabilities in all areas. Kirby has more than 20 years of HR experience and has held HR leadership roles in companies such as Infosys, Symantec and General Electric. Her industry experience crosses technology, financial services and health care. Kirby holds a master's degree in Human Resources from the University of South Carolina and received her bachelor's degree from Coastal Carolina University.

ShowHide Related Items >><<
BNFT Benefitfocus
$10.11 /

+0.17 (+1.71%)

BNFT Benefitfocus
$10.11 /

+0.17 (+1.71%)

08/06/20 Piper Sandler
Benefitfocus price target raised to $30 from $26 at Piper Sandler
06/29/20 Goldman Sachs
Benefitfocus price target raised to $12 from $11 at Goldman Sachs
05/07/20 Piper Sandler
Benefitfocus price target lowered to $26 from $35 at Piper Sandler
04/02/20 Cantor Fitzgerald
Benefitfocus shares attractive at current levels, says Cantor Fitzgerald
BNFT Benefitfocus
$10.11 /

+0.17 (+1.71%)

BNFT Benefitfocus
$10.11 /

+0.17 (+1.71%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.